Brown & Brown, Inc. announces first quarter 2024 results, including total revenues of $1,258 million, an increase of 12.7%; Organic Revenue growth of 8.6%; diluted net income per share of $1.02; Diluted Net Income Per Share – Adjusted of $1.14; and a quarterly dividend of $0.13 per share
Revenues for the first quarter of 2024 under
In addition, the Company today announced that the Board of Directors has declared a regular quarterly cash dividend of
Reconciliation of Commissions and Fees to Organic Revenue (in millions, unaudited) |
|||||||
Three Months Ended |
|||||||
2024 | 2023 | ||||||
Commissions and fees | $ | 1,237 | $ | 1,108 | |||
Profit-sharing contingent commissions | (46 | ) | (27 | ) | |||
Core commissions and fees | $ | 1,191 | $ | 1,081 | |||
Acquisitions | (41 | ) | |||||
Dispositions | (27 | ) | |||||
Foreign Currency Translation | 5 | ||||||
Organic Revenue | $ | 1,150 | $ | 1,059 | |||
Organic Revenue growth | $ | 91 | |||||
Organic Revenue growth % | 8.6 | % |
See information regarding non-GAAP measures presented later in this press release.
Reconciliation of Diluted Net Income Per Share to Diluted Net Income Per Share - Adjusted (unaudited) |
||||||||||||||
Three Months Ended |
Change | |||||||||||||
2024 | 2023 | $ | % | |||||||||||
Diluted net income per share | $ | 1.02 | $ | 0.83 | $ | 0.19 | 22.9 | % | ||||||
Change in estimated acquisition earn-out payables | (0.01 | ) | (0.01 | ) | — | |||||||||
(Gain)/loss on disposal | 0.01 | (0.02 | ) | 0.03 | ||||||||||
Acquisition/Integration Costs | — | 0.01 | (0.01 | ) | ||||||||||
Amortization | 0.12 | 0.12 | — | |||||||||||
1Q23 Nonrecurring Cost | 0.03 | (0.03 | ) | |||||||||||
Diluted Net Income Per Share - Adjusted | $ | 1.14 | $ | 0.96 | $ | 0.18 | 18.8 | % |
See information regarding non-GAAP measures presented later in this press release.
Reconciliation of Income Before Income Taxes to EBITDAC and EBITDAC - Adjusted and Income Before Income Taxes Margin(1) to EBITDAC Margin and EBITDAC Margin - Adjusted (in millions, unaudited) |
|||||||
Three Months Ended |
|||||||
2024 | 2023 | ||||||
Total revenues | $ | 1,258 | $ | 1,116 | |||
Income before income taxes | $ | 364 | $ | 294 | |||
Income Before Income Taxes Margin(1) | 28.9 | % | 26.3 | % | |||
Amortization | 43 | 41 | |||||
Depreciation | 11 | 10 | |||||
Interest | 48 | 47 | |||||
Change in estimated acquisition earn-out payables | (2 | ) | (2 | ) | |||
EBITDAC | $ | 464 | $ | 390 | |||
EBITDAC Margin | 36.9 | % | 34.9 | % | |||
(Gain)/loss on disposal | 2 | (6 | ) | ||||
Acquisition/Integration Costs | — | 3 | |||||
1Q23 Nonrecurring Cost | 11 | ||||||
EBITDAC - Adjusted | $ | 466 | $ | 398 | |||
EBITDAC Margin - Adjusted | 37.0 | % | 35.7 | % |
(1) “Income Before Income Taxes Margin” is defined as income before income taxes divided by total revenues
See information regarding non-GAAP measures presented later in this press release.
Consolidated Statements of Income (in millions, except per share data; unaudited) |
|||||||
Three Months Ended |
|||||||
2024 | 2023 | ||||||
REVENUES | |||||||
Commissions and fees | $ | 1,237 | $ | 1,108 | |||
Investment income | 18 | 7 | |||||
Other | 3 | 1 | |||||
Total revenues | 1,258 | 1,116 | |||||
EXPENSES | |||||||
Employee compensation and benefits | 631 | 571 | |||||
Other operating expenses | 161 | 161 | |||||
Loss/(Gain) on disposal | 2 | (6 | ) | ||||
Amortization | 43 | 41 | |||||
Depreciation | 11 | 10 | |||||
Interest | 48 | 47 | |||||
Change in estimated acquisition earn-out payables | (2 | ) | (2 | ) | |||
Total expenses | 894 | 822 | |||||
Income before income taxes | 364 | 294 | |||||
Income taxes | 71 | 58 | |||||
Net income before non-controlling interests | 293 | 236 | |||||
Less: Net income attributable to non-controlling interests | — | — | |||||
Net income attributable to the Company | $ | 293 | $ | 236 | |||
Net income per share: | |||||||
Basic | $ | 1.03 | $ | 0.83 | |||
Diluted | $ | 1.02 | $ | 0.83 | |||
Weighted average number of shares outstanding: | |||||||
Basic | 281 | 278 | |||||
Diluted | 283 | 279 |
Consolidated Balance Sheets (in millions, except per share data, unaudited) |
|||||||
2024 |
2023 |
||||||
ASSETS | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 581 | $ | 700 | |||
Fiduciary cash | 1,569 | 1,603 | |||||
Short-term investments | 10 | 11 | |||||
Commission, fees, and other receivables | 932 | 790 | |||||
Fiduciary receivables | 1,133 | 1,125 | |||||
Reinsurance recoverable | 65 | 125 | |||||
Prepaid reinsurance premiums | 428 | 462 | |||||
Other current assets | 287 | 314 | |||||
Total current assets | 5,005 | 5,130 | |||||
Fixed assets, net | 272 | 270 | |||||
Operating lease assets | 197 | 199 | |||||
7,386 | 7,341 | ||||||
Amortizable intangible assets, net | 1,592 | 1,621 | |||||
Investments | 21 | 21 | |||||
Other assets | 333 | 301 | |||||
Total assets | $ | 14,806 | $ | 14,883 | |||
LIABILITIES AND EQUITY | |||||||
Current liabilities: | |||||||
Fiduciary liabilities | $ | 2,702 | $ | 2,727 | |||
Losses and loss adjustment reserve | 72 | 131 | |||||
Unearned premiums | 488 | 462 | |||||
Accounts payable | 322 | 459 | |||||
Accrued expenses and other liabilities | 421 | 608 | |||||
Current portion of long-term debt | 875 | 569 | |||||
Total current liabilities | 4,880 | 4,956 | |||||
Long-term debt less unamortized discount and debt issuance costs | 3,009 | 3,227 | |||||
Operating lease liabilities | 178 | 179 | |||||
Deferred income taxes, net | 614 | 616 | |||||
Other liabilities | 338 | 326 | |||||
Equity: | |||||||
Common stock, par value |
30 | 30 | |||||
Additional paid-in capital | 1,003 | 1,027 | |||||
(748 | ) | (748 | ) | ||||
Accumulated other comprehensive loss | (51 | ) | (19 | ) | |||
Non-controlling interests | 9 | - | |||||
Retained earnings | 5,544 | 5,289 | |||||
Total equity | 5,787 | 5,579 | |||||
Total liabilities and equity | $ | 14,806 | $ | 14,883 |
Consolidated Statements of Cash Flows (in millions, unaudited) |
|||||||
Three Months Ended |
|||||||
2024 | 2023 | ||||||
Cash flows from operating activities: | |||||||
Net income before non-controlling interests | $ | 293 | $ | 236 | |||
Adjustments to reconcile net income before non-controlling interests to net cash provided by operating activities: | |||||||
Amortization | 43 | 41 | |||||
Depreciation | 11 | 10 | |||||
Non-cash stock-based compensation | 29 | 24 | |||||
Change in estimated acquisition earn-out payables | (2 | ) | (2 | ) | |||
Deferred income taxes | (1 | ) | 1 | ||||
Net loss/(gain) on sales/disposals of investments, fixed assets and customer accounts | 2 | (5 | ) | ||||
Payments on acquisition earn-outs in excess of original estimated payables | (13 | ) | — | ||||
Changes in operating assets and liabilities, net of effect from acquisitions and divestitures: | |||||||
Commissions, fees and other receivables (increase)/decrease | (142 | ) | (131 | ) | |||
Reinsurance recoverables (increase)/decrease | 60 | 688 | |||||
Prepaid reinsurance premiums (increase)/decrease | 33 | 14 | |||||
Other assets (increase)/decrease | — | (6 | ) | ||||
Losses and loss adjustment reserve increase/(decrease) | (59 | ) | (687 | ) | |||
Unearned premiums increase/(decrease) | 25 | (13 | ) | ||||
Accounts payable increase/(decrease) | (86 | ) | 71 | ||||
Accrued expenses and other liabilities increase/(decrease) | (186 | ) | (169 | ) | |||
Other liabilities increase/(decrease) | 6 | (12 | ) | ||||
Net cash provided by operating activities | 13 | 60 | |||||
Cash flows from investing activities: | |||||||
Additions to fixed assets | (13 | ) | (12 | ) | |||
Payments for businesses acquired, net of cash acquired | (76 | ) | (38 | ) | |||
Proceeds from sales of fixed assets and customer accounts | — | 6 | |||||
Purchases of investments | — | (3 | ) | ||||
Proceeds from sales of investments | 1 | 4 | |||||
Net cash used in investing activities | (88 | ) | (43 | ) | |||
Cash flows from financing activities: | |||||||
Fiduciary receivables and liabilities, net | (26 | ) | (19 | ) | |||
Payments on acquisition earn-outs | (39 | ) | (16 | ) | |||
Payments on long-term debt | (13 | ) | (17 | ) | |||
Borrowings on revolving credit facilities | 150 | — | |||||
Payments on revolving credit facilities | (50 | ) | — | ||||
Repurchase shares to fund tax withholdings for non-cash stock-based compensation | (54 | ) | (36 | ) | |||
Cash dividends paid | (38 | ) | (33 | ) | |||
Non-controlling interest acquired (disposed), net | 3 | — | |||||
Net cash used in financing activities | (67 | ) | (121 | ) | |||
Effect of foreign exchange rate changes in cash and cash equivalents inclusive of fiduciary cash | (11 | ) | 14 | ||||
Net decrease in cash and cash equivalents inclusive of fiduciary cash | (153 | ) | (90 | ) | |||
Cash and cash equivalents inclusive of fiduciary cash at beginning of period | 2,303 | 2,033 | |||||
Cash and cash equivalents inclusive of fiduciary cash at end of period | $ | 2,150 | $ | 1,943 |
Conference call, webcast and slide presentation
A conference call to discuss the results of the first quarter of 2024 will be held on
About Brown & Brown
Forward-looking statements
This press release may contain certain statements relating to future results which are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which are intended to be covered by the safe harbors created by those laws. You can identify these statements by forward-looking words such as “may,” “will,” “should,” “expect,” “anticipate,” “believe,” “intend,” “estimate,” “plan” and “continue” or similar words. We have based these statements on our current expectations about potential future events. Although we believe the expectations expressed in the forward-looking statements included in this press release are based upon reasonable assumptions within the bounds of our knowledge of our business, a number of factors could cause actual results to differ materially from those expressed in any forward-looking statements, whether oral or written, made by us or on our behalf. Many of these factors have previously been identified in filings or statements made by us or on our behalf. Important factors which could cause our actual results to differ, possibly materially from the forward-looking statements in this press release include but are not limited to the following items: the inability to hire, retain and develop qualified employees, as well as the loss of any of our executive officers or other key employees; a cybersecurity attack or any other interruption in information technology and/or data security that may impact our operations or the operations of third parties that support us; acquisition-related risks that could negatively affect the success of our growth strategy, including the possibility that we may not be able to successfully identify suitable acquisition candidates, complete acquisitions, successfully integrate acquired businesses into our operations and expand into new markets; risks related to our international operations, which may result in additional risks or require more management time and expense than our domestic operations to achieve or maintain profitability; the requirement for additional resources and time to adequately respond to dynamics resulting from rapid technological change; the loss of or significant change to any of our insurance company relationships, which could result in loss of capacity to write business, additional expense, loss of market share or material decrease in our commissions; the effect of natural disasters on our profit-sharing contingent commissions, insurer capacity or claims expenses within our capitalized captive insurance facilities; adverse economic conditions, political conditions, outbreaks of war, disasters, or regulatory changes in states or countries where we have a concentration of our business; the inability to maintain our culture or a significant change in management, management philosophy or our business strategy; fluctuations in our commission revenue as a result of factors outside of our control; the effects of sustained inflation or higher interest rates; claims expense resulting from the limited underwriting risk associated with our participation in capitalized captive insurance facilities; risks associated with our automobile and recreational vehicle dealer services (“F&I”) businesses; changes in, or the termination of, certain programs administered by the
Non-GAAP supplemental financial information
This press release contains references to "non-GAAP financial measures" as defined in SEC Regulation G, consisting of Organic Revenue, EBITDAC, EBITDAC Margin, EBITDAC - Adjusted, EBITDAC Margin - Adjusted and Diluted Net Income Per Share - Adjusted. We present these measures because we believe such information is of interest to the investment community and because we believe it provides additional meaningful methods to evaluate the Company’s operating performance from period to period on a basis that may not be otherwise apparent on a GAAP basis due to the impact of certain items that have a high degree of variability, that we believe are not indicative of ongoing performance and that are not easily comparable from period to period. This non-GAAP financial information should be considered in addition to, not in lieu of, the Company’s consolidated income statements and balance sheets as of the relevant date. Consistent with Regulation G, a description of such information is provided below and a reconciliation of such items to GAAP information can be found within this press release as well as in our periodic filings with the
We view Organic Revenue and Organic Revenue growth as important indicators when assessing and evaluating our performance on a consolidated basis and for each of our three segments, because it allows us to determine a comparable, but non-GAAP, measurement of revenue growth that is associated with the revenue sources that were a part of our business in both the current and prior year and that are expected to continue in the future. In addition, we believe Diluted Net Income Per Share - Adjusted provides a meaningful representation of our operating performance and improves the comparability of our results between periods by excluding the impact of the change in estimated acquisition earn-out payables, the impact of amortization of intangible assets and certain other non-recurring or infrequently occurring items. We also view EBITDAC, EBITDAC - Adjusted, EBITDAC Margin and EBITDAC Margin - Adjusted as important indicators when assessing and evaluating our performance, as they present more comparable measurements of our operating margins in a meaningful and consistent manner. As disclosed in our most recent proxy statement, we use Organic Revenue growth, Diluted Net Income Per Share - Adjusted and EBITDAC Margin - Adjusted as key performance metrics for our short-term and long-term incentive compensation plans for executive officers and other key employees.
Beginning
Beginning
Non-GAAP Revenue Measures
- Organic Revenue is our core commissions and fees less: (i) the core commissions and fees earned for the first 12 months by newly acquired operations; (ii) divested business (core commissions and fees generated from offices, books of business or niches sold or terminated during the comparable period); and (iii) Foreign Currency Translation (as defined below). The term “core commissions and fees” excludes profit-sharing contingent commissions and therefore represents the revenues earned directly from specific insurance policies sold and specific fee-based services rendered. Organic Revenue can be expressed as a dollar amount or a percentage rate when describing Organic Revenue growth.
Non-GAAP Earnings Measures
- EBITDAC is defined as income before interest, income taxes, depreciation, amortization and the change in estimated acquisition earn-out payables.
- EBITDAC Margin is defined as EBITDAC divided by total revenues.
- EBITDAC - Adjusted is defined as EBITDAC, excluding (i) (gain)/loss on disposal, (ii) for 2022 and 2023, Acquisition/Integration Costs (as defined below) and (iii) for 2023, the 1Q23 Nonrecurring Cost (as defined below).
- EBITDAC Margin - Adjusted is defined as EBITDAC - Adjusted divided by total revenues.
- Diluted Net Income Per Share - Adjusted is defined as diluted net income per share, excluding the after-tax impact of (i) the change in estimated acquisition earn-out payables, (ii) (gain)/loss on disposal, (iii) for 2022 and 2023, Acquisition/Integration Costs (as defined below), (iv) for 2023, the 1Q23 Nonrecurring Cost (as defined below) and (v) amortization.
Definitions Related to Certain Components of Non-GAAP Measures
- “Acquisition/Integration Costs” means the acquisition and integration costs (e.g., costs associated with regulatory filings, legal/accounting services, due diligence and the costs of integrating our information technology systems) arising out of our acquisitions of
GRP (Jersey) Holdco Limited and its business,Orchid Underwriters Agency andCrossCover Insurance Services , andBdB Limited companies, which are not considered to be normal, recurring or part of the ongoing operations. - “Foreign Currency Translation” means the period-over-period impact of foreign currency translation, which is calculated by applying current-year foreign exchange rates to the various functional currencies in our business to our reporting currency of US dollars for the same period in the prior year.
- “1Q23 Nonrecurring Cost” means approximately
$11.0 million expensed and substantially paid in the first quarter of 2023 to resolve a business matter, which is not considered to be normal, recurring or part of the ongoing operations. - “(Gain)/loss on disposal,” a caption on our consolidated statements of income which reflects net proceeds received as compared to net book value related to sales of books of business and other divestiture transactions, such as the disposal of a business through sale or closure.
Our industry peers may provide similar supplemental non-GAAP information with respect to one or more of these measures, although they may not use the same or comparable terminology and may not make identical adjustments and, therefore comparability may be limited. This supplemental non-GAAP financial information should be considered in addition to, and not in lieu of, the Company's condensed consolidated financial statements.
For more information:
(386) 239-5770
Source:
Democrats’ bill puts controls on health insurance in Illinois
Sen. Gopal, Asw. Donlon Sponsor Bill to Make Pioneering Cancer Treatment Available to All
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News